Ashkan Emadi

4.9k total citations · 1 hit paper
108 papers, 2.9k citations indexed

About

Ashkan Emadi is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ashkan Emadi has authored 108 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 42 papers in Molecular Biology and 25 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ashkan Emadi's work include Acute Myeloid Leukemia Research (46 papers), Acute Lymphoblastic Leukemia research (24 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Ashkan Emadi is often cited by papers focused on Acute Myeloid Leukemia Research (46 papers), Acute Lymphoblastic Leukemia research (24 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Ashkan Emadi collaborates with scholars based in United States, Iran and France. Ashkan Emadi's co-authors include Richard J. Jones, Robert A. Brodsky, Emmanuel S. Antonarakis, Steven D. Gore, Judith E. Karp, Jennifer Ding, Edward A. Sausville, Alison Duffy, Matthew T Crim and Lisa M Wilson and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ashkan Emadi

99 papers receiving 2.9k citations

Hit Papers

Cyclophosphamide and cancer: golden anniversary 2009 2026 2014 2020 2009 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cyclophosphamide and cancer: golden anniversary
    2009 731 citations Ashkan Emadi, Richard J. Jones et al. Nature Reviews Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashkan Emadi United States 22 1.2k 770 724 423 350 108 2.9k
Dennis Carney Australia 20 1.7k 1.4× 590 0.8× 451 0.6× 262 0.6× 345 1.0× 51 3.4k
Angélo Paci France 31 1.0k 0.9× 850 1.1× 413 0.6× 181 0.4× 403 1.2× 201 3.5k
David Mitchell United States 24 1000 0.8× 916 1.2× 305 0.4× 177 0.4× 164 0.5× 81 2.6k
Massimo Zucchetti Italy 40 1.8k 1.5× 1.9k 2.4× 417 0.6× 250 0.6× 421 1.2× 170 4.8k
Xiufen Yang China 18 1.7k 1.5× 684 0.9× 226 0.3× 196 0.5× 173 0.5× 49 2.7k
Gareth J. Veal United Kingdom 32 1.3k 1.1× 1.0k 1.3× 278 0.4× 140 0.3× 289 0.8× 136 3.7k
Raymond J. Hohl United States 40 2.3k 1.9× 1.5k 2.0× 616 0.9× 416 1.0× 818 2.3× 138 4.9k
Brian Booth United States 30 1.6k 1.4× 1.3k 1.7× 518 0.7× 193 0.5× 313 0.9× 77 4.6k
C. Patrick Burns United States 35 1.2k 1.0× 376 0.5× 579 0.8× 261 0.6× 326 0.9× 100 3.4k
Michael Hayes United States 33 1.2k 1.0× 574 0.7× 1.2k 1.7× 294 0.7× 131 0.4× 97 4.1k

Countries citing papers authored by Ashkan Emadi

Since Specialization
Citations

This map shows the geographic impact of Ashkan Emadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashkan Emadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashkan Emadi more than expected).

Fields of papers citing papers by Ashkan Emadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashkan Emadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashkan Emadi. The network helps show where Ashkan Emadi may publish in the future.

Co-authorship network of co-authors of Ashkan Emadi

This figure shows the co-authorship network connecting the top 25 collaborators of Ashkan Emadi. A scholar is included among the top collaborators of Ashkan Emadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashkan Emadi. Ashkan Emadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pradhan, Snigdhendubala, Yongfeng Tong, Akshath R. Shetty, et al.. (2025). Valorization of orange peel via slow pyrolysis: Effect of particle size on biochar characteristics for wastewater remediation. Results in Engineering. 27. 106612–106612. 1 indexed citations
3.
Goloubeva, Olga, James F. Childress, Grace Li, et al.. (2024). Clinical outcomes of patients with acute myeloid leukemia and cardiovascular disease. Leukemia Research. 138. 107456–107456. 2 indexed citations
4.
Bollino, Dominique, et al.. (2024). Dual targeting of glutamine and serine metabolism in acute myeloid leukemia. Frontiers in Oncology. 14. 1326754–1326754. 3 indexed citations
5.
6.
Ali, Moaath K. Mustafa, Jennie Y. Law, Seung‐Tae Lee, et al.. (2022). Impact of FLT3-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study. Biology. 11(6). 916–916. 2 indexed citations
7.
Kapadia, Bandish, Amol C. Shetty, Dominique Bollino, et al.. (2022). Translatome changes in acute myeloid leukemia cells post exposure to pegcrisantaspase and venetoclax. Experimental Hematology. 108. 55–63. 6 indexed citations
8.
Stock, Wendy, Jae H. Park, Ashkan Emadi, et al.. (2021). Safety and Pharmacokinetics of Calaspargase Pegol in Adults with Newly Diagnosed Philadelphia-Negative ALL: A Phase 2/3 Study. Blood. 138(Supplement 1). 4406–4406. 1 indexed citations
9.
Corley, Elizabeth A., Moaath K. Mustafa Ali, Jennie Y. Law, et al.. (2021). The Impact of IDH1c.315C>T Single Nucleotide Polymorphism on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study. Blood. 138(Supplement 1). 4454–4454. 1 indexed citations
10.
Goloubeva, Olga, James F. Childress, Vu H. Duong, et al.. (2020). Impact of Cardiovascular Disease on Clinical Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome. Blood. 136(Supplement 1). 37–38. 1 indexed citations
11.
Emadi, Ashkan, Bandish Kapadia, Dominique Bollino, et al.. (2020). Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia. Leukemia. 35(7). 1907–1924. 23 indexed citations
12.
Sadeghı, Anahita, et al.. (2017). Inappropriate Packed RBC Transfusion in a Tertiary Care Center.. PubMed. 20(2). 83–85. 7 indexed citations
13.
Holtzman, Noa G., et al.. (2017). Promyelocytic sarcoma of the right humerus: an unusual clinical presentation with unique diagnostic and treatment considerations. Clinical Case Reports. 5(11). 1874–1877. 2 indexed citations
14.
Chaer, Firas El, Noa G. Holtzman, Neil C. Porter, et al.. (2017). Durable remission with salvage decitabine and donor lymphocyte infusion (DLI) for relapsed early T-cell precursor ALL. Bone Marrow Transplantation. 52(11). 1583–1584. 6 indexed citations
15.
Emadi, Ashkan, et al.. (2011). Prevalence of G6PD deficiency in neonates referred to Semnan University of Medical Science´s screening Lab. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Rezasoltani, Zahra, et al.. (2010). CAMPARISON OF MRI & ELECTRO DIAGNOSTIC STUDY IN EVALUATION OF PATIENTS WITH CLINICAL RADICULOPATHY IN 501 ARMY HOSPITAL,1387-88. 8(230). 98–103.
17.
Haghshenas, Mohammadreza, et al.. (2009). Evaluation of Multiple Choice Questions in the School of Medicine Mazandaran University of Medical Sciences the First Semester of 2007. SHILAP Revista de lepidopterología. 3 indexed citations
18.
Emadi, Ashkan, Richard J. Jones, & Robert A. Brodsky. (2009). Cyclophosphamide and cancer: golden anniversary. Nature Reviews Clinical Oncology. 6(11). 638–647. 731 indexed citations breakdown →
19.
Segal, Jodi B, Daniel J. Brotman, Ashkan Emadi, et al.. (2009). Predictive Value of Factor V Leiden and Prothrombin G20210A in Adults With Venous Thromboembolism and in Family Members of Those With a Mutation. JAMA. 301(23). 2472–2472. 175 indexed citations
20.
Emadi, Ashkan, Kathleen H. Burns, Bradley Confer, Michael J. Borowitz, & Michael B. Streiff. (2008). Hematological Manifestations of Nephropathic Cystinosis. Acta Haematologica. 119(3). 169–172. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis Carney Breakdown of academic impact, for papers by Angélo Paci Breakdown of academic impact, for papers by David Mitchell Breakdown of academic impact, for papers by Massimo Zucchetti Breakdown of academic impact, for papers by Xiufen Yang Breakdown of academic impact, for papers by Gareth J. Veal Breakdown of academic impact, for papers by Raymond J. Hohl Breakdown of academic impact, for papers by Brian Booth Breakdown of academic impact, for papers by C. Patrick Burns Breakdown of academic impact, for papers by Michael Hayes
Rankless by CCL
2026